rs387906872
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PVS1_SupportingPM2PP5_Moderate
The NM_004544.4(NDUFA10):c.1A>G(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000113 in 1,504,940 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_004544.4 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151830Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000289 AC: 3AN: 103762Hom.: 0 AF XY: 0.0000518 AC XY: 3AN XY: 57936
GnomAD4 exome AF: 0.0000111 AC: 15AN: 1353110Hom.: 0 Cov.: 33 AF XY: 0.0000165 AC XY: 11AN XY: 667618
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151830Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74152
ClinVar
Submissions by phenotype
Mitochondrial complex 1 deficiency, nuclear type 22 Pathogenic:2
Variant summary: NDUFA10 c.1A>G (p.Met1?, aka p.Met1Val) alters the initiation codon and is predicted to result either in absence of the protein or truncation/extension of the encoded protein due to translation initiation at a downstream/upstream codon. No upstream in-frame ATG triplets were found that could generate an N-terminally extended protein product, and although a downstream in-frame ATG triplet was found, (i.e. Met40 in Exon 2), the utilization of Met40 as a start codon would result in an N-terminally truncated protein product, with the loss of the mitochondrial targeting signal (i.e. the 35 N-terminal amino acids; see Dang_2020). The variant allele was found at a frequency of 2.9e-05 in 103762 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. The variant, c.1A>G, has been reported in the literature in a compound heterozygous individual affected with Mitochondrial Complex 1 Deficiency, Nuclear Type 22 (Hoefs_2011), and the authors of this study described a marked decrease of complex I activity in patient derived fibroblasts and muscle tissue, together with a strongly decreased NDUFA10 protein level on Western blot analysis. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at